<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01416480</url>
  </required_header>
  <id_info>
    <org_study_id>AG1321001_ACP3</org_study_id>
    <nct_id>NCT01416480</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Evaluate the Safety and Efficacy of &quot;Theobromine Capsule&quot; as an Antitussive in Acute Cougher</brief_title>
  <official_title>Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of &quot;Theobromine Capsule 300mg&quot; as an Antitussive Agent in Acute Cough Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahn-Gook Pharmaceuticals Co.,Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ahn-Gook Pharmaceuticals Co.,Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to evaluate the antitussive effect of &quot;Theobromine capsule
      300mg&quot; in patients with acute bronchitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is double blinded, randomized, parallel designed, phase III clinical trial to
      evaluate the efficacy and safety of &quot;Theobromine capsule 300mg&quot; versus &quot;Levodropropizine
      syrup&quot; in patients with acute bronchitis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cough remission rate</measure>
    <time_frame>3 days</time_frame>
    <description>cough remission : no cough or 1 short cough in day time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cough recovery rate</measure>
    <time_frame>1 day, 2 days, within 3days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference of DCS score between screening and closing visit.</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>required time for cough remission</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">332</enrollment>
  <condition>Acute Bronchitis</condition>
  <arm_group>
    <arm_group_label>Theobromine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Theobromine capsule 300mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levodropropizine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levodropropizine syrup</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Theobromine 300mg</intervention_name>
    <description>Capsule, b.i.d.</description>
    <arm_group_label>Theobromine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levodropropizine 10mg</intervention_name>
    <description>Syrup, t.i.d.</description>
    <arm_group_label>levodropropizine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient who decided to participate in this clinical trial at his(her) own will and
             agreed in written letter of consent.

          2. Adult aged over 18

          3. Patient who has cough symptom caused by acute bronchitis

          4. Patient who go to see the doctor for severe cough at his(her) own will

          5. DCS score at screening vist sould be over 3.

          6. For fertile woman, HCG test at screening visit shloud be negative.

        patient who will continue to cough more than 1 week.(by physician's judgment)

        Exclusion Criteria:

          1. Patient who is accompanied by the seriously abnormal symptom in respiratory system,
             such as Acute infectious Pulmonary Disease, Tuberculosis, asthma.

          2. Chronic bronchitis including bronchial obstruction

          3. Patient who has clinical history of sensitivity to Xanthine drug.

          4. Patient who has Peptic Ulcer

          5. Patient whose liver or kidney function is seriously abnormal: Including the cases of
             sGOT, sGPT, bilirubin and blood creatinine value exceeding twice of their upper normal
             limit.

          6. Patient whose heart function is abnormal: including the case of showing abnormal EKG
             test value that is clinically significant.

          7. patient who has convulsion or alcoholism.

          8. Patient who has experience to have participated in other clinical trial within two
             months before starting the trial.

          9. Pregnant woman, lactating woman.

         10. Patient who thought to be cured within 3 days without any medicine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ki-Suck Jung, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soo-Taek Uh, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soon Chun Hyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jae Yeol Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Young Kyoon Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea-St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Soon Lee, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Bum Park, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangdong Sacred Heart Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kwan Ho Lee, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung Hyun chang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ewha Womans University Mokdong Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hallym University Medical Center</name>
      <address>
        <city>Anyang</city>
        <state>Gyeonggi-do</state>
        <zip>431-070</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>August 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2011</study_first_posted>
  <last_update_submitted>August 12, 2011</last_update_submitted>
  <last_update_submitted_qc>August 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jung Hoon, Han / Senior Researcher</name_title>
    <organization>Project Development Team / Ahn-Gook Pharmaceuticals Co.,Ltd</organization>
  </responsible_party>
  <keyword>Theobromine</keyword>
  <keyword>cough</keyword>
  <keyword>acute bronchitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Theobromine</mesh_term>
    <mesh_term>Phenylpropanolamine</mesh_term>
    <mesh_term>Chlorpheniramine, phenylpropanolamine drug combination</mesh_term>
    <mesh_term>Dipropizine</mesh_term>
    <mesh_term>Guaifenesin</mesh_term>
    <mesh_term>Antitussive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

